Parkinsonism and cancer

JAMA Neurology

Volumn 70, Issue 3, 2013, Pages 414-415

  Kisby, Glen E ^a   Spencer, Peter S ^b,c  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b Ctr Res Occup Environ Toxicol   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); DNA; MAMMALIAN TARGET OF RAPAMYCIN; METHYLAZOXYMETHANOL; METHYLAZOXYMETHANOL GLUCOSIDE; MICRORNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

CARCINOGENESIS; CELL PROLIFERATION; DEMENTIA; DNA DAMAGE; ENZYME ACTIVITY; GENE DISRUPTION; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HUMAN; INTRACELLULAR SIGNALING; LETTER; MALIGNANT NEOPLASTIC DISEASE; MELANOGENESIS; MELANOMA; MITOSIS; NERVE CELL DIFFERENTIATION; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROSTATE CANCER; SKIN CANCER; UNITED STATES;

EID: 84874914535     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.1283     Document Type: Letter

References (9)

1. Kareus SA, Figueroa KP, Cannon-Albright LA, Pulst SM. Shared predispositions of parkinsonism and cancer: a population-based pedigree-linked study. Arch Neurol. 2012;69(12):1572-1577.
2. Zhang ZX, Anderson DW, Mantel N. Geographic patterns of parkinsonismdementia complex on Guam: 1956 through 1985. Arch Neurol. 1990;47(10): 1069-1074.
3. Spencer P, Fry RC, Kisby GE. Unraveling 50-year-old clues linking neurodegeneration and cancer to cycad toxins: are microRNAs common mediators Front Genet. 2012;3:192.
4. Kisby GE, Fry RC, Lasarev MR, et al. The cycad genotoxin MAM modulates brain cellular pathways involved in neurodegenerative disease and cancer in a DNA damage-linked manner. PLoS One. 2011;6(6):e20911.
5. Spanel P, Smith D, Holland TA, Al Singary W, Elder JB. Analysis of formaldehyde in the headspace of urine from bladder and prostate cancer patients using selected ion flow tube mass spectrometry. Rapid CommunMass Spectrom. 1999;13(14):1354-1359.
6. Devine MJ, Plun-Favreau H, Wood NW. Parkinson's disease and cancer: two wars, one front. Nat Rev Cancer. 2011;11(11):812-823.
7. de Lau LM, Koudstaal PJ, van Meurs JB, Uitterlinden AG, Hofman A, Breteler MM.Methylenetetrahydrofolate reductase C677T genotype and PD. Ann Neurol. 2005;57(6):927-930.
8. Singal R, Ferdinand L, Das PM, Reis IM, Schlesselman JJ. Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk. Int J Oncol. 2004;25(5):1465-1471.
9. Han J, Colditz GA, Hunter DJ. Polymorphisms in the MTHFR and VDR genes and skin cancer risk. Carcinogenesis. 2007;28(2):390-397.